M K Proteins refines and trades edible oils, such as rice bran, sunflower, and soybean oil, and sells industrial by-products like fatty acids and wax. The company earns revenue by processing crude oil into branded and unbranded food products for the Indian market.
The company operates in a highly fragmented and commoditized industry with thin net margins averaging 2.1%. While they claim a quality advantage, the low ROCE (13.8%) and lack of pricing power indicate no durable competitive advantage over other regional refiners.
Management prioritizes reinvestment into refining capacity and working capital, but returns on equity have trended downward. The recent 2:1 bonus issue and 10-for-1 stock split suggest a focus on retail liquidity rather than fundamental value creation.
The investment collapsed as the razor-thin 2.1% net margins were obliterated by a slight uptick in raw material costs and increased competition in the commoditized refining space. The sudden resignation of the statutory auditor in 2025 proved to be a harbinger of deeper accounting irregularities, as the massive gap between reported profits and actual cash flow (0.06 conversion ratio) eventually forced a painful restatement. As trade receivables ballooned and related-party transactions drained liquidity, the company was unable to service its debt, leaving equity holders with a permanent loss of capital in a business that lacked any pricing power to defend itself.
RichFakir rates M K Proteins Ltd's business quality as mediocre — 44/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, M K Proteins Ltd is trading about 38% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on M K Proteins Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of M K Proteins Ltd's fair value is about ₹3 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →